{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:35:00Z","timestamp":1792143300992,"version":"4.4.0"},"reference-count":18,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only potential curative therapy for myelodysplastic syndrome (MDS), recommended in higher risk disease according to the International Prognostic Scoring System (IPSS). We conducted a phase 2 multicenter trial (MDS-ALLO-RISK) investigating whether allogeneic HSCT improves overall survival (OS) in patients with lower-risk MDS who exhibit additional high-risk features (intermediate or higher revised-IPSS risk, thrombocytopenia with &amp;lt;20 \u00d7 109\/L, neutropenia &amp;lt;0.5 \u00d7 109\/L, or failure to 2 lines of therapy). A total of 77 patients (median age, 62.5 years) with low or intermediate-1 IPSS scores were enrolled and stratified based on the presence of a matched HLA donor, 62 patients in the donor arm and 15 without a donor. Despite high remission rates in patients who had received a transplant (67.8% vs 21.4%), the 3-year OS did not significantly differ between arms (57.6% in the donor arm vs 64.3% in the no-donor arm; hazard ratio, 0.75; P = .53). The adjusted analysis using inverse probability of treatment weighting confirmed the lack of survival benefit with HSCT. Transplantation was associated with higher rates of chronic graft-versus-host disease, severe infections, and nonrelapse mortality (24.7%). Although quality of life improved slightly over time in patients who had received a transplant, the difference was not statistically significant. The trial was stopped early due to slow enrollment and futility. The findings highlight the need for improving posttransplant outcomes to justify HSCT in patients with lower-risk MDS with poor prognostic features. This trial was registered at www.clinicaltrials.gov as #NCT02757989.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017035","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:54:40Z","timestamp":1759953280000},"page":"494-504","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability"],"prefix":"10.1182","volume":"10","author":[{"given":"Marie","family":"S\u00e9bert","sequence":"first","affiliation":[{"name":"1Service d\u2019H\u00e9matologie S\u00e9nior, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3492-2778","authenticated-orcid":false,"given":"Sylvain","family":"Thepot","sequence":"additional","affiliation":[{"name":"2Service des Maladies du Sang, Centre Hospitalo-Universitaire Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6745-1127","authenticated-orcid":false,"given":"Thomas","family":"Cluzeau","sequence":"additional","affiliation":[{"name":"3Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-1022","authenticated-orcid":false,"given":"Nicolas","family":"Duployez","sequence":"additional","affiliation":[{"name":"4Laboratoire de Biologie Mol\u00e9culaire, Centre Hospitalier R\u00e9gional Universitaire de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Lef\u00e8bvre","sequence":"additional","affiliation":[{"name":"5Centre Fran\u00e7ais des Porphyries - H\u00f4pital Louis Mourier, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, F-92700 Colombes INSERM, EFS, BIGR U1134, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cendrine","family":"Chaffaut","sequence":"additional","affiliation":[{"name":"6Service de Biostatistique et Informatique M\u00e9dicale, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8717-0824","authenticated-orcid":false,"given":"Corentin","family":"Orvain","sequence":"additional","affiliation":[{"name":"2Service des Maladies du Sang, Centre Hospitalo-Universitaire Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4460-5939","authenticated-orcid":false,"given":"Michael","family":"Loschi","sequence":"additional","affiliation":[{"name":"3Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire Nice, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5463-6686","authenticated-orcid":false,"given":"Pierre","family":"Peterlin","sequence":"additional","affiliation":[{"name":"7Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[{"name":"7Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire de Nantes, Nantes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-2742","authenticated-orcid":false,"given":"Maud","family":"D\u2019Aveni","sequence":"additional","affiliation":[{"name":"8Service d\u2019H\u00e9matologie, Centre Hospitalier R\u00e9gional Universitaire Nancy, Nancy, Universit\u00e9 de Lorraine, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-5442","authenticated-orcid":false,"given":"Marie Th\u00e9r\u00e8se","family":"Rubio","sequence":"additional","affiliation":[{"name":"8Service d\u2019H\u00e9matologie, Centre Hospitalier R\u00e9gional Universitaire Nancy, Nancy, Universit\u00e9 de Lorraine, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-6029","authenticated-orcid":false,"given":"Odile","family":"Rauzy","sequence":"additional","affiliation":[{"name":"9Service de M\u00e9decine Interne, Centre Hospitalo-Universitaire Toulouse, Universit\u00e9 de Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-6198","authenticated-orcid":false,"given":"Anne","family":"Huynh","sequence":"additional","affiliation":[{"name":"10Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Charbonnier","sequence":"additional","affiliation":[{"name":"11Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire Amiens, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sapena","sequence":"additional","affiliation":[{"name":"12Groupe Francophone des my\u00e9lodysplasies, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatiha","family":"Chermat","sequence":"additional","affiliation":[{"name":"12Groupe Francophone des my\u00e9lodysplasies, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-2937","authenticated-orcid":false,"given":"Patrice","family":"Ceballos","sequence":"additional","affiliation":[{"name":"13Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4418-4932","authenticated-orcid":false,"given":"Gaelle","family":"Fossard","sequence":"additional","affiliation":[{"name":"14Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Nguyen","sequence":"additional","affiliation":[{"name":"15Service d\u2019h\u00e9matologie, H\u00f4pital de la Piti\u00e9 Salp\u00e9tri\u00e8re, Assistance Publique H\u00f4pitaux de Paris, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Park","sequence":"additional","affiliation":[{"name":"16Service d\u2019H\u00e9matologie, Centre Hospitalo-Universitaire Grenoble Alpes, Universit\u00e9 Grenoble Alpes, Saint-Martin-d'H\u00e8res, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-8766","authenticated-orcid":false,"given":"Lionel","family":"Ad\u00e8s","sequence":"additional","affiliation":[{"name":"1Service d\u2019H\u00e9matologie S\u00e9nior, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6222-4753","authenticated-orcid":false,"given":"R\u00e9gis","family":"Peffault de Latour","sequence":"additional","affiliation":[{"name":"17Service d\u2019H\u00e9matologie-Greffe, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1267-9546","authenticated-orcid":false,"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[{"name":"4Laboratoire de Biologie Mol\u00e9culaire, Centre Hospitalier R\u00e9gional Universitaire de Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[{"name":"1Service d\u2019H\u00e9matologie S\u00e9nior, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6449-4730","authenticated-orcid":false,"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[{"name":"6Service de Biostatistique et Informatique M\u00e9dicale, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1388-9876","authenticated-orcid":false,"given":"Marie","family":"Robin","sequence":"additional","affiliation":[{"name":"17Service d\u2019H\u00e9matologie-Greffe, H\u00f4pital Saint-Louis, Assistance Publique H\u00f4pitaux de Paris, Universit\u00e9 de Paris Cit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"14","key":"2026012709265329800_bib1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJMra1904794","article-title":"Myelodysplastic syndromes","volume":"383","author":"Cazzola","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"2026012709265329800_bib2","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International Scoring System for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"issue":"12","key":"2026012709265329800_bib3","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International Prognostic Scoring System for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2026012709265329800_bib4","doi-asserted-by":"crossref","first-page":"EVIDoa2200008","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"2","key":"2026012709265329800_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood-2004-01-0338","article-title":"A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome","volume":"104","author":"Cutler","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2026012709265329800_bib6","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2012.05.003","article-title":"Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine","volume":"18","author":"Platzbecker","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"2026012709265329800_bib7","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1200\/JCO.2012.46.8652","article-title":"Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis","volume":"31","author":"Koreth","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"2026012709265329800_bib8","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/leu.2015.37","article-title":"HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM","volume":"29","author":"Robin","year":"2015","journal-title":"Leukemia"},{"issue":"30","key":"2026012709265329800_bib9","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.20.03380","article-title":"Biologic assignment trial of reduced-intensity hematopoietic cell transplantation based on donor availability in patients 50-75 years of age with advanced myelodysplastic syndrome","volume":"39","author":"Nakamura","year":"2021","journal-title":"J Clin Oncol"},{"issue":"30","key":"2026012709265329800_bib10","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1200\/JCO.20.02724","article-title":"Comparison between 5-azacytidine treatment and allogeneic stem-cell transplantation in elderly patients with advanced MDS according to donor availability (VidazaAllo study)","volume":"39","author":"Kr\u00f6ger","year":"2021","journal-title":"J Clin Oncol"},{"issue":"18","key":"2026012709265329800_bib11","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1182\/blood.2024025131","article-title":"Clinical-genomic profiling of MDS to inform allo-HSCT: recommendations from an international panel on behalf of the EBMT","volume":"145","author":"Gurnari","year":"2025","journal-title":"Blood"},{"issue":"2","key":"2026012709265329800_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jtct.2022.11.014","article-title":"Hematopoietic cell transplantation in the management of myelodysplastic syndrome: an evidence-based review from the American Society for Transplantation and Cellular Therapy Committee on practice guidelines","volume":"29","author":"DeFilipp","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"20","key":"2026012709265329800_bib13","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2026012709265329800_bib14","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1182\/blood-2007-06-096966","article-title":"Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences","volume":"110","author":"Sorror","year":"2007","journal-title":"Blood"},{"issue":"26","key":"2026012709265329800_bib15","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"2026012709265329800_bib16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/leu.2013.16","article-title":"Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents","volume":"27","author":"Kelaidi","year":"2013","journal-title":"Leukemia"},{"issue":"21","key":"2026012709265329800_bib17","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1200\/JCO.2007.15.4906","article-title":"Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome","volume":"26","author":"J\u00e4dersten","year":"2008","journal-title":"J Clin Oncol"},{"issue":"14","key":"2026012709265329800_bib18","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1200\/JCO.2016.71.3271","article-title":"Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents","volume":"35","author":"Park","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/2\/494\/2498500\/blooda_adv-2025-017035-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/2\/494\/2498500\/blooda_adv-2025-017035-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:26:59Z","timestamp":1769524019000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/2\/494\/547646\/Transplantation-in-patients-with-lower-risk-MDS-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017035","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1,27]]},"published":{"date-parts":[[2026,1,16]]}}}